Folgen
Sue Fletcher
Sue Fletcher
Professor
Bestätigte E-Mail-Adresse bei murdoch.edu.au
Titel
Zitiert von
Zitiert von
Jahr
Regulation of eukaryotic gene expression by the untranslated gene regions and other non-coding elements
LW Barrett, S Fletcher, SD Wilton
Cellular and molecular life sciences 69, 3613-3634, 2012
6862012
ALS genetics, mechanisms, and therapeutics: where are we now?
R Mejzini, LL Flynn, IL Pitout, S Fletcher, SD Wilton, PA Akkari
Frontiers in neuroscience 13, 1310, 2019
6162019
Functional amounts of dystrophin produced by skipping the mutated exon in the mdx dystrophic mouse
QL Lu, CJ Mann, F Lou, G Bou-Gharios, GE Morris, S Xue, S Fletcher, ...
Nature medicine 9 (8), 1009-1014, 2003
5962003
Antisense-induced exon skipping and synthesis of dystrophin in the mdx mouse
CJ Mann, K Honeyman, AJ Cheng, T Ly, F Lloyd, S Fletcher, JE Morgan, ...
Proceedings of the National Academy of Sciences 98 (1), 42-47, 2001
5392001
Antisense oligonucleotide-induced exon skipping across the human dystrophin gene transcript
SD Wilton, AM Fall, PL Harding, G McClorey, C Coleman, S Fletcher
Molecular Therapy 15 (7), 1288-1296, 2007
3582007
Specific removal of the nonsense mutation from the mdx dystrophin mRNA using antisense oligonucleotides
SD Wilton, F Lloyd, K Carville, S Fletcher, K Honeyman, S Agrawal, ...
Neuromuscular disorders 9 (5), 330-338, 1999
3571999
Antisense oligonucleotide-induced exon skipping restores dystrophin expression in vitro in a canine model of DMD
G McClorey, HM Moulton, PL Iversen, S Fletcher, SD Wilton
Gene therapy 13 (19), 1373-1381, 2006
3492006
Morpholino antisense oligonucleotide induced dystrophin exon 23 skipping in mdx mouse muscle
BL Gebski, CJ Mann, S Fletcher, SD Wilton
Human molecular genetics 12 (15), 1801-1811, 2003
2822003
Improved antisense oligonucleotide induced exon skipping in the mdx mouse model of muscular dystrophy
CJ Mann, K Honeyman, G McClorey, S Fletcher, SD Wilton
The Journal of Gene Medicine: A cross‐disciplinary journal for research on …, 2002
2732002
Dystrophin expression in the mdx mouse after localised and systemic administration of a morpholino antisense oligonucleotide
S Fletcher, K Honeyman, AM Fall, PL Harding, RD Johnsen, SD Wilton
The Journal of Gene Medicine: A cross‐disciplinary journal for research on …, 2006
2692006
Morpholino oligomer–mediated exon skipping averts the onset of dystrophic pathology in the mdx mouse
S Fletcher, K Honeyman, AM Fall, PL Harding, RD Johnsen, JP Steinhaus, ...
Molecular Therapy 15 (9), 1587-1592, 2007
2342007
Prevention of dystrophic pathology in severely affected dystrophin/utrophin-deficient mice by morpholino-oligomer-mediated exon-skipping
A Goyenvalle, A Babbs, D Powell, R Kole, S Fletcher, SD Wilton, ...
Molecular Therapy 18 (1), 198-205, 2010
1682010
The influence of antisense oligonucleotide length on dystrophin exon skipping
PL Harding, AM Fall, K Honeyman, S Fletcher, SD Wilton
Molecular Therapy 15 (1), 157-166, 2007
1542007
Target selection for antisense oligonucleotide induced exon skipping in the dystrophin gene
SJ Errington, CJ Mann, S Fletcher, SD Wilton
The Journal of Gene Medicine: A cross‐disciplinary journal for research on …, 2003
1472003
Induced dystrophin exon skipping in human muscle explants
G Mcclorey, AM Fall, HM Moulton, PL Iversen, JE Rasko, M Ryan, ...
Neuromuscular Disorders 16 (9-10), 583-590, 2006
1442006
Antisense oligonucleotides for inducing exon skipping and methods of use thereof
SD Wilton, S Fletcher, G McClorey
US Patent 7,807,816, 2010
1342010
Antisense oligonucleotides for inducing exon skipping and methods of use thereof
SD Wilton, S Fletcher, G McClorey
US Patent 8,232,384, 2012
1272012
Cell-penetrating peptide–morpholino conjugates alter pre-mRNA splicing of DMD (Duchenne muscular dystrophy) and inhibit murine coronavirus replication in vivo
HM Moulton, S Fletcher, BW Neuman, G McClorey, DA Stein, S Abes, ...
Biochemical Society Transactions 35 (4), 826-828, 2007
1252007
Antisense oligonucleotides for inducing exon skipping and methods of use thereof
SD Wilton, S Fletcher, G McClorey
US Patent 7,960,541, 2011
1192011
Proteomic profiling of antisense‐induced exon skipping reveals reversal of pathobiochemical abnormalities in dystrophic mdx diaphragm
P Doran, SD Wilton, S Fletcher, K Ohlendieck
Proteomics 9 (3), 671-685, 2009
1172009
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20